Johannesburg — Multinational drug giant Bristol-Myers Squibb (BMS) has awarded a
royalty-free licence of one of its anti-AIDS drugs to two generic drug
companies in South Africa and India.
According to the Associated Press, BMS on Wednesday announced an
agreement licensing South Africa's Aspen Pharmacare and India's Emcure
Pharmaceuticals to manufacture and sell cheaper generic versions of
antiretroviral drug Reyataz, which was approved for use in the US in
2003.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article